Public links to publications



1. V. Craig Jordan. Selective estrogen receptor modulation: Concept and consequences in cancer. Cancer Cell, 5:207-213, 2004.

2. Hong Liu, Eun-Sook Lee, Csaba Gajdos, Sandra Timm Pearce, Bin Chen, Clodia Osipo, Jessica Loweth, Kevin McKian, Alexander De Los Reyes, Laura Wing, V. Craig Jordan. Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo. J Natl Cancer Inst, 95(21):1586-97, 2003.

3. Clodia Osipo, Csaba Gajdos, Hong Liu, Bin Chen, V. Craig Jordan. Paradoxical action of fulvestrant on estradiol-induced regression of tamoxifen-stimulated breast cancer. J Natl Cancer Inst, 95:1597-1607, 2003.

4. Joan S. Lewis, Clodia Osipo, Kathleen Meeke, V. Craig Jordan. Estradiol-induced apoptosis in a breast cancer cell line resistant to estrogen deprivation. J Steroid Biochem, 94:131-141, 2005.

5. Heather E. Cunliffe, Markus Ringner, Sven Bilke, Robert L. Walker, Jennifer M. Cheung, Yidong Chen, Paul S. Meltzer. The gene expression response of breast cancer to growth regulators: Patterns and correlation with tumor expression profiles. Cancer Res, 63:7158-7166, 2003.

6. Eric A. Ariazi, Joan S. Lewis-Wambi, Shaun D. Gill, Jennifer R. Pyle, Jennifer L. Ariazi, Helen R. Kim, Catherine G.N. Sharma, Fernando Cordera, Heather A. Shupp, Tianyu Li, V. Craig Jordan. Emerging principles for the development of resistance to antihormonal therapy: Implications for the clinical utility of fulvestrant. J Steroid Biochem, 102:128–138, 2006.